💬
[E8494] Gromen highlights China's strategic positioning: virtual monopoly on active pharmaceutical ingredients (80% of US hospital supply), expanding global refining capacity, 32% discount on Iranian energy in non-USD, anti-satellite capabilities, and hypersonic missiles putting US carriers at risk. These advantages create asymmetric leverage in trade negotiations, though framed more as geopolitical risk than direct equity opportunity.
commentary · 2025-12-06